Log in to save to my catalogue

ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phe...

ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f542924285bc411ab2ef82b8bba3d188

ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Intermediate-length repeat expansions in ATAXIN-2 (ATXN2) are the strongest genetic risk factor for amyotrophic lateral sclerosis (ALS). At the molecular level, ATXN2 intermediate expansions enhance TDP-43 toxicity and pathology. However, whether this triggers ALS pathogenesis at the cellular and functional level remains unknown. Here, we combine p...

Alternative Titles

Full title

ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f542924285bc411ab2ef82b8bba3d188

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f542924285bc411ab2ef82b8bba3d188

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-51676-0

How to access this item